Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST

Published on October 21, 2020 in New York, NY

Back to all press releases

October 21, 2020 – New York – Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that it will report its financial results for the third quarter of 2020 together with a business update on Thursday, November 5, 2020, after the close of the US market. The announcement will be followed by a conference call at 8:00 AM EST / 2:00 PM CET on Friday, November 6, 2020, prior to the open of the US market.

The live dial-in information for the conference call is:

US & Canada only: +1 (877) 407-3104
International: +1 (201) 493-6792
In addition, a replay of the call will be available until November 20, 2020 by calling +1 (877) 660-6853 (Toll Free US & Canada); +1 (201) 612-7415 (Toll Free International).
Conference ID: 13688263

Download the PDF file